Kazia Therapeutics Says Two Paxalisib Abstracts Accepted for 2026 Breast Cancer Symposium
The abstracts will explore paxalisib’s tumor and immune reprogramming activity, with poster presentations at the 2026 San Antonio Breast Cancer Symposium.
Related stories
Oracle Details $20 Billion Plan to Fund AI Buildout
Oracle disclosed details of its previously announced plan to raise $20 billion to fund AI infrastructure expansion. Its stock fell Monday.
M impact | EQUITY | Nov 02, 2026, 03:50 PM UTC
Engineers India Shares Jump 15% to Two-Week High After Q2 Results
Engineers India shares closed Monday up 15% at Rs.290, a two-week high, after upbeat September-quarter results. The stock has gained 44% in 2026.
M impact | EQUITY | Nov 02, 2026, 03:48 PM UTC
World Stocks Rebound as Oil Falls and Strong Data Is Published
Global equities rebounded as oil prices declined and strong economic data was published.
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Carnelian, HDFC AMC and L&T Acquire 2.9% Stake in EAAA India Alternatives
The investors collectively acquired the stake through open-market transactions on EAAA India Alternatives’ first day of trading, November 2.
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Global stocks rise as oil falls and data prove positive
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Global Stocks Rise as Oil Pullback and Solid Data Lift Sentiment
Global stocks were headed higher after oil prices fell sharply, reversing some of the gloom from Friday’s US tech rout. The Nasdaq was up 1.2% and the S&P 500 rose 1% at the open.
M impact | EQUITY | Nov 02, 2026, 03:46 PM UTC